To compare visual field progression after trabeculectomy in eyes showing a postoperative intraocular pressure (IOP) less than or equal to 16 mmHg and eyes with an IOP of 17 to 21 mmHg.
Methods.
A retrospective cohort study design was used. A total of 101 eyes of 101 consecutive patients undergoing trabeculectomy for primary open-angle glaucoma (POAG) with a postoperative IOP less than or equal to 21 mmHg were divided into two groups: Group 1 included eyes showing a postoperative IOP less than or equal to 16 mmHg at all visits and Group 2 included eyes with a postoperative IOP between 17 and 21mmHg. In turn, each of these groups was divided into two subgroups according to whether treatment was required for IOP control. Glaucomatous visual field control during follow-up was compared between the subject groups.
Results.
Kaplan-Meier analysis revealed glaucomatous visual field control in 98.53% of the eyes in Group 1 and 89.06% of those in Group 2 at 5 years, the difference between the groups being significant.
Conclusions.
Glaucomatous disease progression is less frequent when IOP is less than or equal to 16 mmHg in all the follow-up visits after trabeculectomy. The results indicate a definite benefit of low IOP in visual field control.
ChenP.P., ParkR.J.Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology2000; 107: 1688–92.
6.
HeijlA., LeskeM.C., BengtssonB.Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol2002; 120: 1268–79.
7.
LeskeM.C., HeijlA., HusseinM.Factors for glaucoma progression and the effect of treatment. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol2003; 121: 48–56.
8.
KassM.A., HeuerD.K., HigginbothamE.J.The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypotensive medications delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 701–13.
9.
GordonM.O., BeiserJ.A., BrandtJ.D.The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 714–20.
10.
WilsonM.R., KosokoO., CowanC.L.Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol2002; 134: 399–405.
11.
The AGIS Investigators.The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol2000; 130: 429–40.
12.
GrantW.M., BurkeJ.F.Why do some people go blind from glaucoma?Ophthalmology1982; 89: 991–8.
13.
MaoL.K., StewartW.C., ShieldsM.B.Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol1991; 111: 51–5.
14.
Collaborative Normal-Tension Collaborative Group.Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol1998; 126: 487–97.
15.
Collaborative Normal-Tension Collaborative Group, The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol1998; 126: 498–505.
16.
BergeåB., BodinL., SvedberghB.Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology1999; 106: 997–1005.
17.
Terminology and Guidelines for Glaucoma (European Guidelines)1st ed.Savona, Italy: Editrice DOGMA, 1998.
18.
Terminology and Guidelines for Glaucoma (European Guidelines)2nd ed.Savona, Italy: Editrice DOGMA, 2003.
19.
WatsonP.G.Surgery of the glaucomas. Br J Ophthalmol1972; 56: 299–308.
20.
WatsonP.G.Effectiveness of trabeculectomy in glaucoma. Am J Ophthalmol1975; 79: 831–45.
21.
DavidR., FreedmanJ., LuntzM.H.Comparative study of Watson's and Cairn's trabeculectomies in a black population with open angle glaucoma. Br J Ophthalmol1977; 61: 117–9.
22.
García SánchezJ., Fernández VilaP., López AbadC., TeijelJ.Trabeculectomía en el glaucoma crónico simple. Estudio a largo plazo. Arch Soc Esp Oftal1985; 49: 95–100.
23.
LazaroC., Benitez-del-CastilloJ.M., CastilloA.Lens fluorophotometry after trabeculectomy in primary open-angle glaucoma. Ophthalmology2002; 109: 76–9.
Nouri-MahdaviK., BrigattiL., WeitzmanM., CaprioliJ.Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology1995; 102: 1760–9.
27.
KosekiN., AraieM., ShiratoS., YamamotoS.Effect of trabeculectomy on visual field performance in central 30° field in progressive normal-tension glaucoma. Ophthalmology1997; 104: 197–201.
28.
BhandariA., CrabbD.P., PoinoosawmyD.Effect of surgery on visual field progression in normal tension glaucoma. Ophthalmology1997; 104: 1131–7.
The AGIS Investigators.The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol2002; 134: 499–512.
31.
MembreyW.L., BunceC., PoinoosawmyD.P.Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2. Visual field progression. Br J Ophthalmol2001; 85: 696–701.
32.
KatzJ.Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology1999; 106: 391–5.
33.
LichterP.R., MuschD.C., GillespieB.W.Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology2001; 108: 1943–53.
34.
ChenP.P.Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology2002; 109: 2093–9.
35.
AraujoM.L., FeuerW.J., AndersonD.R.Evaluation of baseline-related suprathreshold testing for quick determination of visual field nonprogression. Arch Ophthalmol1993; 111: 365–9.
36.
Nouri-MahdaviK., BrigattiL., WeitzmanM., CaprioliJ.Comparison of methods to detect visual field progression in glaucoma. Ophthalmology1997; 104: 1228–36.
37.
VestiE., JohnsonC.A., ChauhanC.Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci2003; 44: 3873–9.
38.
The AGIS Investigators.The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors of failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol2002; 134: 481–98.
39.
Nouri-MahdaviK., CaprioliJ., ColemanA.L., HoffmanD., GaasterlandD.Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol2005; 123: 193–9.
40.
WernerE.B., DranceS.M., SchulzerM.Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol1977; 95: 1374–7.
41.
Nouri-MahdaviK., HoffmanD., ColemanA.L.Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Ophthalmology2004; 111: 1627–35.
42.
HeijlA., BengtssonB.The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol1996; 114: 19–22.
43.
WernerE.B., KrupinT., AdelsonA.Effect of patient experience on the results of automated perimetry in glaucoma suspects patients. Ophthalmology1990; 97: 44–8.
44.
WildJ.M., SearleA.E., Dengler-HarlesM., O'NeillE.C.Long-term follow-up of baseline learning and fatigue effects in automated perimetry of glaucoma and ocular hypertensive patients. Acta Ophthalmol (Copenh)1991; 69: 210–6.
45.
KulzeJ.C., StewartW.C., SutherlandS.E.Factors associated with a learning effect in glaucoma patients using automated perimetry. Acta Ophthalmol (Copenh)1990; 68: 681–6.
46.
BrandtJ.D., BeiserJ.A., KassM.A., GordonM.O.Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology2001; 108: 1779–88.
